BVF INC/IL – Protagonist Therapeutics, Inc. Transaction History
BVF INC/IL portfolio value:
$0
portfolio value
BVF INC/IL quarter portfolio value change:
+6.57%
quarter
Protagonist Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -1.10M shares | -8.75M | $8.43 | 0 |
| Q2 2022 | share | Decrease | -73.54% | -3.07M shares | -90.30M | $7.91 | 1.10M |
| Q1 2022 | share | Increase | +14.55% | 531.46K shares | -25.83M | $23.68 | 4.18M |
| Q4 2021 | share | Decrease | -6.41% | -250K shares | 55.75M | $34.25 | 3.65M |
| Q3 2021 | share | Increase | +3.93% | 147.66K shares | -99.34M | $17.72 | 3.90M |
| Q2 2021 | share | Decrease | -5.19% | -205.35K shares | 65.93M | $44.88 | 3.75M |
| Q1 2021 | share | Decrease | -7.35% | -314.13K shares | 16.39M | $25.9 | 3.95M |
| Q4 2020 | share | Increase | +80.15% | 1.90M shares | 39.77M | $20.16 | 4.27M |
| Q3 2020 | share | Increase | +0.21% | 5K shares | 4.57M | $19.55 | 2.37M |
| Q2 2020 | share | Increase | +241.88% | 1.67M shares | 36.91M | $17.66 | 2.36M |
| Q1 2020 | share | Increase | +1.44% | 9.8K shares | 76K | $7.06 | 692.43K |
| Q4 2019 | share | 0.00% | 0 shares | -3.38M | $7.05 | 682.63K | |
| Q3 2019 | share | Decrease | -35.83% | -381.17K shares | -4.68M | $12.01 | 682.63K |
| Q2 2019 | share | Decrease | -5.29% | -59.45K shares | -1.23M | $12.11 | 1.06M |
| Q1 2019 | share | Decrease | -31.49% | -516.20K shares | 3.08M | $12.57 | 1.12M |
| Q4 2018 | share | Decrease | -37.38% | -978.50K shares | -15.90M | $6.73 | 1.63M |
| Q3 2018 | share | Increase | +84.63% | 1.2M shares | 17.41M | $10.29 | 2.61M |
| Q2 2018 | share | Increase | +249.60% | 1.01M shares | 6.04M | $6.72 | 1.41M |
| Q1 2018 | share | Increase | +37.90% | 111.48K shares | -2.63M | $8.59 | 405.6K |
| Q4 2017 | share | Increase | 0.00% | 294.11K shares | 6.11M | $20.8 | 294.11K |
| Q4 2016 | share | Decrease | -100.00% | -375K shares | -7.92M | $21.99 | 0 |
| Q3 2016 | share | Increase | 0.00% | 375K shares | 7.92M | $21.13 | 375K |